Antonio B. Casella
Londrina, PR, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: May 05, 2026
Outcomes of and Surgical Technique for Treatment With High-Dose Aflibercept.
Journal: Journal of vitreoretinal diseases
Published: July 14, 2025
Correction: Sight threatening diabetic retinopathy in patients with macular telangiectasia type 2.
Journal: International journal of retina and vitreous
Published: March 26, 2024
Sight threatening diabetic retinopathy in patients with macular telangiectasia type 2.
Journal: International journal of retina and vitreous
Published: January 14, 2024
The Flavonoid Hesperidin Methyl Chalcone Targets Cytokines and Oxidative Stress to Reduce Diclofenac-Induced Acute Renal Injury: Contribution of the Nrf2 Redox-Sensitive Pathway.
Journal: Antioxidants (Basel, Switzerland)
Published: June 10, 2022
Choroidal ischemia as one cardinal sign in giant cell arteritis.
Journal: International journal of retina and vitreous
Published: February 24, 2022
Intense Acute Swimming Induces Delayed-Onset Muscle Soreness Dependent on Spinal Cord Neuroinflammation.
Journal: Frontiers in pharmacology
Published: June 30, 2021
Birdshot retinochoroiditis in Brazil: a multicenter review of 40 patients.
Journal: International journal of retina and vitreous
Published: April 27, 2021
The citrus flavanone naringenin attenuates zymosan-induced mouse joint inflammation: induction of Nrf2 expression in recruited CD45+ hematopoietic cells.
Journal: Inflammopharmacology
Published: November 21, 2018
Naringenin Eye Drops Inhibit Corneal Neovascularization by Anti-Inflammatory and Antioxidant Mechanisms.
Journal: Investigative ophthalmology & visual science
Published: November 09, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026